These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8063427)

  • 1. Humoral immune response to the Trypanosoma cruzi complement regulatory protein as an indicator of parasitologic clearance in human Chagas' disease.
    Norris KA; Galvão LM; Schrimpf JE; Cançado JR; Krettli AU
    Infect Immun; 1994 Sep; 62(9):4072-4. PubMed ID: 8063427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
    Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
    Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.
    Krautz GM; Galvão LM; Cançado JR; Guevara-Espinoza A; Ouaissi A; Krettli AU
    J Clin Microbiol; 1995 Aug; 33(8):2086-90. PubMed ID: 7559953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
    Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen.
    Paranhos-Bacalla GS; Santos MR; Cotrim PC; Rassi A; Jolivet M; Camargo ME; Da Silveira JF
    Parasite Immunol; 1994 Mar; 16(3):165-9. PubMed ID: 8208589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Trypanosoma-decay accelerating factor antibodies in mice and humans infected with Trypanosoma cruzi.
    Tambourgi DV; Cavinato RA; De Abreu CM; Peres BA; Kipnis TL
    Am J Trop Med Hyg; 1995 Jun; 52(6):516-20. PubMed ID: 7611557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection.
    Godsel LM; Tibbetts RS; Olson CL; Chaudoir BM; Engman DM
    J Clin Microbiol; 1995 Aug; 33(8):2082-5. PubMed ID: 7559952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lytic antibodies in Trypanosoma cruzi-infected persons with low parasitemia.
    Zulantay I; Venegas J; Apt W; Solari A; Sanchez G
    Am J Trop Med Hyg; 1998 Jun; 58(6):775-9. PubMed ID: 9660462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
    Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
    J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is It Possible to Intervene in the Capacity of
    Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
    Front Immunol; 2021; 12():789145. PubMed ID: 34975884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.
    Matsumoto TK; Hoshino-Shimizu S; Nakamura PM; Andrade HF; Umezawa ES
    J Clin Microbiol; 1993 Jun; 31(6):1486-92. PubMed ID: 8314991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the virulence of T. cruzi strains, complement regulatory protein expression levels, and the ability to elicit lytic antibody production.
    Henrique PM; Marques T; da Silva MV; Nascentes GAN; de Oliveira CF; Rodrigues V; Gómez-Hernández C; Norris KA; Ramirez LE; Meira WSF
    Exp Parasitol; 2016 Nov; 170():66-72. PubMed ID: 27614283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
    Almeida IC; Ferguson MA; Schenkman S; Travassos LR
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human humoral immunity to hsp70 during Trypanosoma cruzi infection.
    Engman DM; Dragon EA; Donelson JE
    J Immunol; 1990 May; 144(10):3987-91. PubMed ID: 2110215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
    Umekita LF; Ramos DP; Barbaro KC; Mota I
    Immunol Lett; 1999 Nov; 70(2):73-6. PubMed ID: 10569694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral autoimmune response in Chagas' disease: Trypanosoma cruzi ribosomal antigens as immunizing agents.
    Levin MJ; Kaplan D; Ferrari I; Arteman P; Vazquez M; Panebra A
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):205-10. PubMed ID: 7506093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein.
    Díez H; Guzmán F; Alba MP; Cuéllar A; Thomas MC; López MC; Rosas F; Velasco V; González JM; Patarroyo ME; Puerta CJ
    Peptides; 2007 Aug; 28(8):1520-6. PubMed ID: 17683828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.